Skip to main content
2025 AANS Annual Scientific Meeting Main banner
Back

    Adnan Siddiqui, MD, PhD, FAANS

    Vice Chairman and Professor of Neurosurgery
    University at Buffalo

    Dr. Adnan H. Siddiqui is a UB Distinguished Professor and Vice Chairman in the Department of Neurosurgery at the State University of New York at Buffalo’s Jacobs School of Medicine and Biomedical Sciences. He has special interest and expertise in the performance of complementary microsurgical, radiosurgical and endovascular techniques for the comprehensive management of cerebrovascular conditions. This spectrum of disease includes aneurysms and arteriovenous malformations, as well as dural, cavernous and spinal fistulae. He has special interests in endovascular management of acute ischemic stroke, as well as endovascular and microsurgical management of extracranial and intracranial vascular occlusive disease.

    Dr. Siddiqui has over 600 peer reviewed publications, more than 50 chapters, over 40,000 citations and an H index of 90. He is particularly proud of representing Buffalo and the US at most major cerebrovascular conferences around the world with over 300 international presentations to date. He has designed, conducted and lead multiple major national and international clinical trials and currently serves as National and International PI for multiple major funded multi-site trials.

    He serves as the CEO and CMO of the Jacobs Institute which is focused on entrepreneurship, development and education opportunities with partners in the medical technology industry to advance the care of patients with vascular diseases. He also leads the Canon Stroke and Vascular Research Center at University at Buffalo and serves as the Director of the Neurosurgical Stroke Service at the Gates Vascular Institute in Buffalo, one of the busiest Comprehensive Stroke Services in New York State and the United States.

    Disclosure(s): Abbott Laboratories, Asahi Intecc Co. Ltd., Canon Medical Systems USA, Inc., Carotix Medical, LLC, CerebrovaKP, Cerenovus, Contego Medical, Inc., Cordis, Endostream Medical, Ltd, FreeOx Biotech, SL,: Consultant (Ongoing); Adona Medical, Inc., Basecamp Vascular SAS, Bend IT Technologies, Ltd., BlinkTBI, Inc, Borvo Medical, Inc., CerebrovaKP, Code Zero Medical, Inc., Cognition Medical, Collavidence, Inc., Contego Medical, Inc., CVAID Ltd., E8, Inc., Endostream Medical: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Cerenovus EXCELLENT and ARISE II Trial; Medtronic SWIFT PRIME, VANTAGE, EMBOLISE and SWIFT DIRECT Trials; Terumo Neuro (formerly MicroVention) FRED Trial & CONFIDENCE Study; MUSC POSITIVE Trial; Penumbra 3D Separator Trial, COMPASS Trial,: Advisor (Ongoing); FreeOx Biotech, SL, Galaxy Therapeutics, Inc., Hyperion Surgical, Inc., Imperative Care, Inc., InspireMD, Ltd., Instylla, Inc., IRRAS, AB, Launch NY, Inc., Neurolutions, Inc., Neurovascular Diagnostics, Inc., NeXtGen Biologics: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Hyperfine Operations, Inc., Imperative Care , InspireMD, Ltd., IRRAS AB, Medtronic, Minnetronix Neuro, Inc., Peijia Medical, Perflow Medical, Ltd., Piraeus Medical, Inc., Prometheus Therapeutics, Inc., Q’Apel Medical, Inc.,: Consultant (Ongoing), Consultant (Ongoing); INVEST Trial, MIVI neuroscience EVAQ Trial; Rapid Medical SUCCESS Trial; InspireMD C-GUARDIANS IDE Pivotal Trial: Advisor (Ongoing); Patent No. US 11,464,528 B2, Date: October 11, 2022, CLOT RETRIEVAL SYSTEM FOR REMOVING OCCLUSIVE CLOT FROM A BLOOD VESSEL, Applicant and Assignee: Neuravi Limited (Galway), Role: Co-Inventor: Royalty Recipient (Ongoing); Peijia Medical, PerFlow Medical, Ltd., Physician X, LLC, Piraeus Medical, Inc., Prometheus Therapeutics, Inc., Q’Apel Medical, Inc., QAS.ai, Inc., Radical Catheter Technologies, Inc., Rist Neurovascular, Inc. (Purchased 2020 by Medtronic: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Sense Diagnostics, Inc., Serenity Medical, Inc., Silk Road Medical, Sim & Cure, Spinnaker Medical, Inc., StimMed, LLC, Synchron, Inc., Tegus Medical, GmbH, T.G. Medical, Inc., Tulavi Therapeutics, Inc.,: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Vastrax, LLC,, Viseon, Inc., Viz.ai, Whisper Medical, Inc., Willow Medtech, Inc: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)

    Presentation(s):